These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 19476597
1. Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD. Kobayashi S, Suzuki S, Niikawa H, Sugawara T, Yanai M. Respirology; 2009 Jul; 14(5):675-9. PubMed ID: 19476597 [Abstract] [Full Text] [Related]
2. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Bölükbas S, Eberlein M, Eckhoff J, Schirren J. Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351 [Abstract] [Full Text] [Related]
3. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids. Perng DW, Wu CC, Su KC, Lee YC, Perng RP, Tao CW. Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333 [Abstract] [Full Text] [Related]
5. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, UPLIFT Study Investigators. N Engl J Med; 2008 Oct 09; 359(15):1543-54. PubMed ID: 18836213 [Abstract] [Full Text] [Related]
6. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS. Respir Med; 2007 Dec 09; 101(12):2464-71. PubMed ID: 17719763 [Abstract] [Full Text] [Related]
11. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients. Ichinose M, Fujimoto T, Fukuchi Y. Respir Med; 2010 Feb 09; 104(2):228-36. PubMed ID: 19969446 [Abstract] [Full Text] [Related]
12. The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis. Wu Q, Li G, Lei WI, Zhou X. Respirology; 2009 Jul 09; 14(5):666-74. PubMed ID: 19402836 [Abstract] [Full Text] [Related]
14. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD. Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S. Osaka City Med J; 2007 Jun 09; 53(1):25-34. PubMed ID: 17867631 [Abstract] [Full Text] [Related]
15. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study. Jung KS, Park HY, Park SY, Kim SK, Kim YK, Shim JJ, Moon HS, Lee KH, Yoo JH, Lee SD, Korean Academy of Tuberculosis and Respiratory Diseases study group, Korea Chronic Obstructive Pulmonary Disease study group. Respir Med; 2012 Mar 09; 106(3):382-9. PubMed ID: 21975275 [Abstract] [Full Text] [Related]
16. Tiotropium in COPD patients not previously receiving maintenance respiratory medications. Adams SG, Anzueto A, Briggs DD, Menjoge SS, Kesten S. Respir Med; 2006 Sep 09; 100(9):1495-503. PubMed ID: 16698259 [Abstract] [Full Text] [Related]